Merit Medical Systems (NASDAQ:MMSI) Updates FY 2025 Earnings Guidance

Merit Medical Systems (NASDAQ:MMSI) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share guidance of 3.580-3.700 for the period, compared to the consensus earnings per share estimate of 3.740. The company issued revenue guidance of $1.5 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on MMSI. Piper Sandler reissued an “overweight” rating and issued a $116.00 target price (up previously from $114.00) on shares of Merit Medical Systems in a research note on Wednesday, January 29th. Raymond James boosted their price objective on Merit Medical Systems from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Tuesday, December 31st. Robert W. Baird increased their price objective on Merit Medical Systems from $107.00 to $109.00 and gave the company an “outperform” rating in a research note on Thursday, October 31st. Needham & Company LLC lifted their target price on shares of Merit Medical Systems from $109.00 to $122.00 and gave the stock a “buy” rating in a research note on Wednesday, January 29th. Finally, Barrington Research upped their price target on shares of Merit Medical Systems from $114.00 to $115.00 and gave the company an “outperform” rating in a report on Wednesday, January 29th. Two investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Merit Medical Systems currently has a consensus rating of “Moderate Buy” and a consensus target price of $109.80.

Merit Medical Systems Trading Down 1.4 %

Shares of NASDAQ:MMSI traded down $1.46 on Tuesday, hitting $102.05. The company had a trading volume of 783,463 shares, compared to its average volume of 515,152. The firm’s 50-day simple moving average is $102.66 and its two-hundred day simple moving average is $99.81. The firm has a market capitalization of $5.95 billion, a price-to-earnings ratio of 50.02, a P/E/G ratio of 2.34 and a beta of 0.87. The company has a quick ratio of 3.82, a current ratio of 5.36 and a debt-to-equity ratio of 0.57. Merit Medical Systems has a 1 year low of $70.70 and a 1 year high of $111.45.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings data on Tuesday, February 25th. The medical instruments supplier reported $0.93 EPS for the quarter, topping the consensus estimate of $0.82 by $0.11. Merit Medical Systems had a net margin of 9.05% and a return on equity of 15.61%. Equities analysts anticipate that Merit Medical Systems will post 3.37 earnings per share for the current fiscal year.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.